[MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM]

Jia-Ye Hua1, Ying Feng1, Ying Pang1

  • 1Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, Guangdong Province, China.

Abstract

Insights

MicroRNA-181a (miR-181a) promotes acute myeloid leukemia (AML) cell proliferation by targeting the tumor suppressor ATM. This finding identifies miR-181a as an oncogene in AML pathogenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • MicroRNAs (miRNAs) play critical roles in cancer development and progression.
  • Understanding miRNA function and regulatory mechanisms is crucial for AML treatment.

Purpose of the Study:

  • To investigate the function of miR-181a in AML.
  • To identify target genes regulated by miR-181a.
  • To elucidate the regulatory mechanism of miR-181a in AML pathogenesis.

Main Methods:

  • Transfection of HL-60 AML cells with miR-181a analog.
  • Cell proliferation assays (CCK-8).
  • Bioinformatic prediction and database analysis of miRNA targets.
  • Dual luciferase reporter gene assays.
  • Western blot analysis.
  • Analysis of patient leukemia cells.

Main Results:

  • Overexpression of miR-181a significantly enhanced HL-60 cell proliferation.
  • miR-181a directly suppressed the activity of a reporter gene containing the ATM 3'-UTR.
  • miR-181a significantly downregulated ATM expression in leukemia cells.
  • miR-181a levels were significantly increased in AML patients and negatively correlated with ATM expression.

Conclusions:

  • miR-181a acts as an oncogene in AML.
  • miR-181a promotes cancer cell proliferation by targeting the tumor suppressor ATM.
  • Regulation of ATM by miR-181a is a key mechanism in AML pathogenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K